NOTCH1 and central nervous system cancer: In glioma, γ-secretase inhibitors (GSIs) that suppress Notch pathway enhanced the sensitivity of glioma stem cells to radiation at clinically relevant doses; knockdown of Notch1 or Notch2 sensitized glioma stem cells to radiation and impaired xenograft tumor formation [62, 64].